151 related articles for article (PubMed ID: 2576939)
1. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
[TBL] [Abstract][Full Text] [Related]
2. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract][Full Text] [Related]
3. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
5. Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma.
Takai S; Tateishi H; Nishisho I; Miki T; Motomura K; Miyauchi A; Kato M; Ikeuchi T; Yamamoto K; Okazaki M
Jpn J Cancer Res; 1987 Sep; 78(9):894-8. PubMed ID: 2889715
[TBL] [Abstract][Full Text] [Related]
6. Oncogene and growth factor expression in MEN 2 and related tumors.
Moley JF; Wallin GK; Brother MB; Kim M; Wells SA; Brodeur GM
Henry Ford Hosp Med J; 1992; 40(3-4):284-8. PubMed ID: 1362425
[TBL] [Abstract][Full Text] [Related]
7. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
[TBL] [Abstract][Full Text] [Related]
8. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.
Yang KP; Nguyen CV; Castillo SG; Samaan NA
Anticancer Res; 1990; 10(2B):527-33. PubMed ID: 1972009
[TBL] [Abstract][Full Text] [Related]
9. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
[TBL] [Abstract][Full Text] [Related]
10. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
Mulligan LM; Gardner E; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1993 Mar; 6(3):166-77. PubMed ID: 7682102
[TBL] [Abstract][Full Text] [Related]
11. Closing in on the MEN2A locus.
Simpson NE; Kidd KK
Henry Ford Hosp Med J; 1989; 37(3-4):100-5. PubMed ID: 2576936
[TBL] [Abstract][Full Text] [Related]
12. Mapping of the genes around MEN2A locus using pulsed-field gel electrophoresis.
Tanaka N; Miki T; Yamamoto M; Nakura J; Okazaki M; Miya A; Mori T; Takai S
Jinrui Idengaku Zasshi; 1990 Dec; 35(4):325-30. PubMed ID: 1982737
[TBL] [Abstract][Full Text] [Related]
13. Loss of the same alleles of HRAS1 and D11S151 in two independent pancreatic cancers from a patient with multiple endocrine neoplasia type 1.
Yoshimoto K; Iizuka M; Iwahana H; Yamasaki R; Saito H; Saito S; Sekiya T
Cancer Res; 1989 May; 49(10):2716-21. PubMed ID: 2565762
[TBL] [Abstract][Full Text] [Related]
14. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.
Herfarth KK; Wick MR; Marshall HN; Gartner E; Lum S; Moley JF
Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950
[TBL] [Abstract][Full Text] [Related]
15. Pheochromocytoma in multiple endocrine neoplasia type II: an example of the two-hit theory of neoplasia.
Cerny JC; Jackson CE; Talpos GB; Yott JB; Lee MW
Surgery; 1982 Nov; 92(5):849-52. PubMed ID: 6127813
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome.
Samaan NA; Yang KP; Schultz P; Hickey RC
Henry Ford Hosp Med J; 1989; 37(3-4):132-7. PubMed ID: 2576946
[TBL] [Abstract][Full Text] [Related]
17. Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation.
Morrison PJ; Hadden DR; Hughes AE; Kennedy L; Russell CJ; Nevin NC
Q J Med; 1991 Jul; 80(291):597-603. PubMed ID: 1682970
[TBL] [Abstract][Full Text] [Related]
18. Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma.
Grauer A; Raue F; Gagel RF
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):613-35. PubMed ID: 1979773
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia 2 (MEN 2)/MEN 2A (Sipple syndrome).
Kousseff BG
Dermatol Clin; 1995 Jan; 13(1):91-7. PubMed ID: 7712656
[TBL] [Abstract][Full Text] [Related]
20. Genetic mechanisms of neoplasia in MEN 2.
Jackson CE; Norum RA
Henry Ford Hosp Med J; 1989; 37(3-4):116-9. PubMed ID: 2576940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
